| pubmed-article:14519633 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0008976 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0144576 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0205390 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0549178 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0678046 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0205179 | lld:lifeskim |
| pubmed-article:14519633 | lifeskim:mentions | umls-concept:C0935915 | lld:lifeskim |
| pubmed-article:14519633 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:14519633 | pubmed:dateCreated | 2003-10-1 | lld:pubmed |
| pubmed-article:14519633 | pubmed:abstractText | Squalamine is an antitumor agent that has been shown to have antiangiogenic activity in animal models. This Phase I/IIA study was designed to assess the safety, clinical response, and pharmacokinetics of squalamine when administered as a 5-day continuous infusion in conjunction with standard chemotherapy every 3 weeks in patients with stage IIIB (pleural effusion) or stage IV non-small cell lung cancer. | lld:pubmed |
| pubmed-article:14519633 | pubmed:language | eng | lld:pubmed |
| pubmed-article:14519633 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:14519633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:14519633 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:14519633 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:14519633 | pubmed:issn | 1078-0432 | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:HammondLisa... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:SchillerJoan... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:BekeleB... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:CarboneDavid... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:HerbstRoy SRS | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:WilliamsJon... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:TranHai THT | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:AllgoodVictor... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:HolroydKennet... | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:HaitHowardH | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:DesaiAvinashA | lld:pubmed |
| pubmed-article:14519633 | pubmed:author | pubmed-author:SolomonStephe... | lld:pubmed |
| pubmed-article:14519633 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:14519633 | pubmed:day | 15 | lld:pubmed |
| pubmed-article:14519633 | pubmed:volume | 9 | lld:pubmed |
| pubmed-article:14519633 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:14519633 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:14519633 | pubmed:pagination | 4108-15 | lld:pubmed |
| pubmed-article:14519633 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:meshHeading | pubmed-meshheading:14519633... | lld:pubmed |
| pubmed-article:14519633 | pubmed:year | 2003 | lld:pubmed |
| pubmed-article:14519633 | pubmed:articleTitle | A phase I/IIA trial of continuous five-day infusion of squalamine lactate (MSI-1256F) plus carboplatin and paclitaxel in patients with advanced non-small cell lung cancer. | lld:pubmed |
| pubmed-article:14519633 | pubmed:affiliation | Department of Thoracic/Head and Neck Medical Oncology and Biostatistics, The University of Texas M. D. Anderson Cancer Center, Houston, TX 77030, USA. | lld:pubmed |
| pubmed-article:14519633 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:14519633 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:14519633 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:14519633 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:14519633 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
| pubmed-article:14519633 | pubmed:publicationType | Clinical Trial, Phase I | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:14519633 | lld:pubmed |
